Staying up-to-date has never been simpler. Sign up for the today! BERKELEY, Calif., May 6, 2013 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that Paul Rubin, the ...
[Published BioSpace - May 07 2013]